An International Continence Society (ICS) report on the terminology for single-use body worn absorbent incontinence products.


Journal

Neurourology and urodynamics
ISSN: 1520-6777
Titre abrégé: Neurourol Urodyn
Pays: United States
ID NLM: 8303326

Informations de publication

Date de publication:
11 2020
Historique:
received: 30 07 2020
accepted: 31 07 2020
pubmed: 12 9 2020
medline: 23 2 2021
entrez: 11 9 2020
Statut: ppublish

Résumé

In 2016, the International Continence Society (ICS) Standardization Steering Committee appointed a working group to address the confusing plethora of synonyms currently used to describe single-use body worn absorbent incontinence products by recommending preferred terminology. An online questionnaire was posted in 2016/17 inviting input from stakeholders internationally. The data were analyzed and conclusions progressively refined through working group discussions, an open meeting at the 2017 annual ICS conference, and a review of further iterations-including from the parent ICS Standardization Committee-until consensus was reached. Partway in, the International Organization for Standardization started a project with similar scope and the two organizations liaised to harmonize their conclusions while respecting each other's processes. A hundred people from 18 countries responded to the questionnaire. About a third (32.2%) of those declaring their nationality were from the UK and a further third (34.5%) from other English-speaking countries. Two-thirds (67.8%) lived in Europe; around a quarter (23%) in North America; and 9.2% in Australasia. Seven main design categories of products were identified and, while clear consensus was readily achieved in naming some of them, others required more work to determine the best term among multiple contenders. The working group concluded that the seven product design categories should be called: (a) pads; (b) unbacked pads; (c) male pads; (d) male pouches; (e) pull-on pads (protective underwear); (f) all-in-ones (wrap-around pads, adult briefs); and (g) belted pads (belted products), in which the bracketed terms are judged acceptable (though not preferred) alternatives.

Identifiants

pubmed: 32914896
doi: 10.1002/nau.24488
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

2031-2039

Informations de copyright

© 2020 The Authors. Neurourology and Urodynamics Published by Wiley Periodicals LLC.

Références

Fonda D, Abrams P. Cure sometimes, help always-a “continence paradigm” for all ages and conditions. Neurourol Urodyn. 2006;25(3):290-292.
Bo K, Frawley H H, Haylen BT, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for the conservative and non-pharamacological management of female pelvic floor dysfunction. Neurourol Urodyn. 2017;36(2):221-244.
Cottenden A, Fader M, Beekman D, et al. Management with Continence Products. In: Abrams P, Cardozo L, Wagg A, Wein A, eds. “Incontinence”. Sixth edition. Bristol: International Continence Society; 2017:2303-2426.
Fader M, Cottenden A, Getliffe K, et al. Absorbent products for urinary/faecal incontinence: a comparative evaluation of key product designs. Health Technol Assess. 2008;12(29):iii-iv-ix-185.
Shigeta Y, Nakagami G, Sanada H, Konya C, Sugama J. Factors influencing intact skin in women with incontinence using absorbent products: results of a cross-sectional, comparative study. Ostomy Wound Manage. 2010;56(12):26-28-30-33.
Bliss DZ, Lewis J, Hasselman K, Savik K, Lowry A, Whitebird R. Use and evaluation of disposable absorbent products for managing fecal incontinence by community-living people. J Wound Ostomy Continence Nurs. 2011;38(3):289-297.
Tamai N, Kaitani T, Takehara K, Oe M, Nagase T, Murayama R. Evaluation of skin temperature humidity and comfort of two types of absorbent products for urinary incontinence. J Japanese Soc Wound Ostomy Continence Manag. 2012;16:345-352.
Sugama J, Sanada H, Shigeta Y, Nakagami G, Konya C. Efficacy of an improved absorbent pad on incontinence-associated dermatitis in older women: cluster randomized controlled trial. BMC Geriatr. 2012;12:22.
Fader MJ, Cottenden AM, Gage HM, et al. Individual budgets for people with incontinence: results from a “shopping” experiment within the British National Health Service. Health Expect. 2012;17(2):186-196.
Gray M, Beeckman D, Bliss DZ, et al. Incontinence-associated dermatitis: a comprehensive review and update. J Wound Ostomy Continence Nurs. 2012;39:61.
Clarke-O'Neill S, Farbrot A, Lagerstedt Eidrup M-L, Cottenden A, Fader M. An exploratory study of skin problems experienced by UK nursing home residents using different pad designs. J Wound Ostomy Continence Nurs. 2015;42(6):621-631.
Gray M, Kent D, Ermer-Seltun J, McNichol L. Assessment, selection, use, and evaluation of body-worn absorbent products for adults with incontinence: a WOCN Society Consensus Conference. J Wound Ostomy Continence Nurs. 2018;45(3):243-264. https://doi.org/10.1097/WON.0000000000000431
DeMarinis M, Kaschak TR, Newman DK. Absorbent products for incontinence. In: Newman DK, Rovner ES, Wein AJ, eds. Clinical Application of Urologic Catheters and Products. Switzerland: Springer International Publishing; 2018:149-172.
Yearwood Martin C, Murphy C, Cotterill N, Williams S, Cottenden A, Fader M. Development and psychometric evaluation of ICIQ-PadPROM: a quality of life questionnaire to assess the treatment effect of absorbent continence products. Neurourol Urodyn. 2018;37(5):1650-1657. https://doi.org/10.1002/nau.23389

Auteurs

Mandy Fader (M)

School of Health Sciences, University of Southampton, Southampton, UK.

Alan Cottenden (A)

Department of Medical Physics and Bioengineering, University College London, London, UK.

Chris Chatterton (C)

Independent Researcher, Berkhamstead, UK.

Helena Engqvist (H)

Independent Consultant, Jönköping, Sweden.

Sharon Eustice (S)

Bladder & Bowel Specialist Service, Cornwall Partnership NHS Foundation Trust, Bodmin, UK.

Diane K Newman (DK)

Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

Joan Ostaszkiewicz (J)

National Ageing Research Institute, Melbourne, Australia.

Mary H Palmer (MH)

School of Nursing, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.

Tara Willson (T)

Patient representative, London, UK.

Bernard Haylen (B)

Faculty of Medicine, University of New South Wales, Sydney, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH